Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

COCIR Welcomes Balanced Approach Of The Medical Devices Regulation

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

ShiftMed Skilltrade Partnership Targets Allied Health...

ShiftMed has entered into a strategic collaboration with Skilltrade...

SS Innovations Advances SSI Mantra Telesurgery...

SS Innovations International, Inc. has completed a long-distance robotic...

NAMSA and Lexitas Launch Ophthalmic MedTech...

NAMSA and Lexitas Pharma Services have entered into a...
COCIR welcomes the endorsements on 15 June of the agreement on the Medical Devices Regulation (MDR) by the Council's Permanent Committee (COREPER) and by the European Parliament’s Environment, Public Health and Food Safety (ENVI) Committee. 
COCIR and its members view this endorsement as an important step in bringing this process closer to its conclusion and potential adoption later this year. However, COCIR still believes that once adopted, important work remains during the implementation phase to ensure realistic rules for regulators, industry and other stakeholders that minimise unnecessary bureaucracy and red tape.
Nicole Denjoy, COCIR Secretary General said; “COCIR and its member companies are actively and carefully analysing the consolidated negotiated text. This will allow for appropriate planning for timely compliance to the MDR at the point when applied across the European Union (expected in 2019-2020). However, we remain concerned by the transition period of three years.” She added; “It is also evident that secondary legislation is of importance to COCIR and its member companies. We will evaluate in greater depth once those will start to become available”.
“We continue to call for smart regulations, supported by state-of-art standards. Together, these will ensure the highest level of safety and quality for patients and citizens while simultaneously fostering innovation” she concluded. 
The consolidated negotiated text will now undergo legal review and translation into the EU’s 24 official languages. This should be finalised before the end of the year/beginning of next year.
For more information, contact:
 
Nicole Denjoy 
COCIR Secretary General        
Tel: +32 (0)2 706 8961
denjoy@cocir.org      
Colin Mackay
COCIR Communications Senior Advisor
Tel: +32 (0) 473 43 07 52  
press@cocir.org

Never miss a healthcare headline

Healthcare moves fast – stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

ShiftMed Skilltrade Partnership Targets Allied Health Gaps

ShiftMed has entered into a strategic collaboration with Skilltrade...

SS Innovations Advances SSI Mantra Telesurgery Innovation

SS Innovations International, Inc. has completed a long-distance robotic...

NAMSA and Lexitas Launch Ophthalmic MedTech Partnership

NAMSA and Lexitas Pharma Services have entered into a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »